Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

OBJECTIVES: This purpose of this study was to examine clinical-pathologic factors – particularly smoking and brain metastases – in EGFR mutation positive (M+) lung adenocarcinoma (ADC) to determine their impact on survival in patients treated with first line EGFR TKI. METHODS: A retrospective review...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Jain, Amit, Lim, Cindy, Gan, Eugene MingJin, Ng, David Zhihao, Ng, Quan Sing, Ang, Mei Kim, Takano, Angela, Chan, Kian Sing, Tan, Wu Meng, Kanesvaran, Ravindran, Toh, Chee Keong, Loo, Chian Min, Hsu, Anne Ann Ling, Devanand, Anantham, Lim, Chong Hee, Koong, Heng Nung, Koh, Tina, Fong, Kam Weng, Yap, Swee Peng, Kim, Su Woon, Chowbay, Balram, Oon, Lynette, Lim, Kiat Hon, Lim, Wan Teck, Tan, Eng Huat, Tan, Daniel Shao Weng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4425557/
https://ncbi.nlm.nih.gov/pubmed/25955322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0123587
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak